Copyright
©The Author(s) 2022.
World J Hepatol. Sep 27, 2022; 14(9): 1790-1803
Published online Sep 27, 2022. doi: 10.4254/wjh.v14.i9.1790
Published online Sep 27, 2022. doi: 10.4254/wjh.v14.i9.1790
Figure 11 T2-weighted hyperintensity and diffusion-weighted imaging signal percentage at pre-stereotactic body radiation therapy and follow-ups.
T2W: T2-weighted; DWI: Diffusion-weighted imaging.
- Citation: Serafini A, Ruggeri V, Inchingolo R, Gatti M, Guarneri A, Maino C, Ippolito D, Grazioli L, Ricardi U, Faletti R. Liver magnetic resonance imaging for evaluation of response to treatment after stereotactic body radiation therapy of hepatocellular carcinoma. World J Hepatol 2022; 14(9): 1790-1803
- URL: https://www.wjgnet.com/1948-5182/full/v14/i9/1790.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i9.1790